
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CLIP-170 CRISPR/Cas9 KO Plasmid (m) | sc-425158 | 20 µg | $397.00 |
Clip1 encodes CLIP-170, a microtubule plus-end–tracking protein that links dynamic microtubule tips to cortical sites and organelles to coordinate intracellular transport and cell architecture. CLIP-170 participates in regulation of microtubule polymerization, kinetochore–microtubule attachment during mitosis, and trafficking of vesicular and protein complexes via interactions with dynein/dynactin and other +TIP networks. Through these roles, Clip1 contributes to processes such as cell polarization, migration, and spindle organization that are frequently perturbed in proliferative and neurodevelopmental contexts. Altered microtubule dynamics and chromosome segregation fidelity associated with CLIP-170–dependent pathways are relevant to studying mechanisms linked to genomic instability and cytoskeletal dysfunction in disease models.
CLIP-170 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Clip1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Clip1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Clip1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish CLIP-170 protein expression.
This CRISPR knockout system enables efficient generation of Clip1-deficient cell models for investigation of CLIP-170 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.